Screening of Monoclonal Antibodies from Integrated Phage and Mammalian Cell Display Libraries.

Diao Yu, Huixian Li, Yujia Jin, Yu Kong, Tianlei Ying, Yanling Wu, Chao Tu

Abstract read

In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diao YuKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Huixian LiBiomissile Corporation, Shanghai, China.

Yujia JinKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Yu KongKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Tianlei YingKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai, China. tlying@fudan.edu.cn.

Yanling WuKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) and Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Chao TuBiomissile Corporation, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both phage display and mammalian cell display technologies have inherent advantages and limitations in antibody screening. Here, we introduce an innovative methodology integrating these two platforms for simultaneous affinity screening of full-length IgG antibodies. This novel strategy leverages the high-throughput capabilities of phage display, while harnessing mammalian cell display to effectively filter out antibodies with suboptimal affinity or expression. By merging these technologies, this method aims to accelerate the discovery of monoclonal antibodies with improved affinity and reduced immunogenicity.

Indexed as

Antibodies, MonoclonalCell Surface Display TechniquesPeptide LibraryAnimalsAntibody AffinityBacteriophagesEnzyme-Linked Immunosorbent AssayFlow CytometryHumansImmunoglobulin GAntibodies, MonoclonalImmunoglobulin GPeptide LibraryAntibody screeningELISAFACSMammalian cell displayPhage display

Identifiers

PMID42129089

DOI10.1016/j.chom.2017.08.011

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.